Production of Biopolymeric Microparticles to Improve Cannabigerol Bioavailability
Abstract Cannabigerol’s (CBG) therapeutic effects are limited by its poor water solubility and low dissolution rate. To improve these properties,…
Abstract Cannabigerol’s (CBG) therapeutic effects are limited by its poor water solubility and low dissolution rate. To improve these properties,…
Abstract Introduction: Cannabidiol (CBD) has a variety of pharmacological effects including antiepileptic, antispasmodic, anxiolytic and anti-inflammatory among other pharmacological effects.…
Abstract Globally, cancer is one of the primary causes of both morbidity and mortality. To prevent cancer from getting worse,…
Abstract Apigenin is one of the most widespread flavonoids in the plant kingdom. For centuries, apigenin-containing plant preparations have been…
Abstract Introduction: Cannabidiol (CBD) has several potential benefits and therapeutic uses, especially in pain, inflammation, and anxiety. CBD has high…
Abstract Poorly water-soluble drugs demonstrate significant challenge in pharmaceutical development, which is linked to their limited oral bioavailability and therapeutic…
Abstract The bioavailability levels of cannabidiol (CBD) and tetrahydrocannabinol (THC) determine their pharmacological effects. Therefore, for medical purposes, it is…
Abstract Hempseed (Cannabis sativa) is one of the most promising sources of plant proteins. It contains approximately 24% (w/w) protein,…
Abstract Cannabidiol (CBD), one of the most promising constituents isolated from Cannabis sativa, exhibits diverse pharmacological actions. However, the applications…
Abstract Cannabis sativa plants contain a multitude of bioactive substances, which show broad variability between different plant strains. Of the…